TABLE 2.
Percentage of Proliferating Cells in Epidermis From Children With NSCLP and VWS†
| Patient-Clinical Phenotype | Percentage of PCNA+ Cells‡ | Average | P* |
|---|---|---|---|
| 1-VWS | 12.87 | ||
| 2-VWS | 10.23 | ||
| Average VWS | 11.55 | ||
| 3-NSCLP | 5.89 | ||
| 4-NSCLP | 4.44 | ||
| 5-NSCLP | 5.56 | ||
| 6-NSCLP | 5.19 | ||
| 7-NSCLP | 3.96 | ||
| 8-NSCLP | 8.62 | ||
| 9-NSCLP | 2.5 | ||
| Average NSCLP | 5.16 | .004 |
†
NSCLP = nonsyndromic cleft lip and palate; VWS = Van der Woude syndrome; PCNA = Proliferating Cell Nuclear Antigen.
‡
Data are means of two to four technical replicates.
*
P < .05 is considered significant after Student’s t test between the 2 groups.